In a global survey of people with hypermobile Ehlers-Danlos syndrome, 98.9% reported chronic pain and 84.3% reported gut disorders. They carried an average of 24 other conditions. They waited an average of 22.1 years from first symptom to diagnosis. Ehlers-Danlos chronic pain is usually treated one joint at a time. Meanwhile the gut, built on the same collagen, gets sent to a different clinic. The video version of Chapter 7 of The Angry Gut, Collagen Is the Wall, Not the Paint, lays out what the gut wall is made of. Here the lens is pain. Why does a connective-tissue body so often hurt, struggle to digest and run out of energy all at once? And what can a pain practice do about it?
Ehlers-Danlos chronic pain rarely travels alone
A 2026 meta-analysis pooled the gut data in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder. The odds of chronic gut symptoms were 4.29 times those of controls. Among these patients, 65.3% had at least one chronic gut symptom. And 44.2% met the criteria for a disorder of gut-brain interaction. Outside the gut, chronic fatigue led at 49%. Then came migraine at 38.2%, dizziness on standing (orthostatic intolerance) at 35.9% and fibromyalgia at 27.9%. The large survey adds dysautonomia (a misfiring automatic nervous system) in 71.4%.
That is not a list of random bad luck. It is one tissue problem showing up in the joints, the gut, the blood vessels and the automatic nervous system at the same time. Pain in these patients hits many organs by nature. A plan that treats only the sore shoulder has treated the least connected part of the patient.
The delay is its own injury. A patient disbelieved for two decades is a patient whose pain went untreated for two decades. They carry the shame of normal tests that never explained anything. It is the same trap behind why fibromyalgia test results so often come back normal.
Collagen is structure, not cosmetics
If collagen were just for looks, a broken collagen gene would be a skin problem. It is not. Vascular Ehlers-Danlos comes from a defect in type III procollagen. In one cohort (group of patients) drawn from a diagnostic lab, bowel rupture made up about a quarter of all complications. Median survival was 48 years. Among 81 women with the vascular form who became pregnant, pregnancy complications killed 12. And the specific COL3A1 mutation did not predict which disaster would strike.
The mirror image makes the same point from the other side. In collagenous sprue, collagen gets laid down in the wrong layer beneath the gut lining, and absorption collapses. Median age at diagnosis is 65. Where a drug history was recorded, 30 of 38 patients had taken a drug linked to sprue-like injury. Most often it was an angiotensin receptor blocker for blood pressure. On repeat biopsy, 37 of 50 got better. That is a pooled set of case reports, not a risk estimate. Still, it makes the pill list the first thing to read before anyone calls a bowel problem idiopathic (of unknown cause).
The motility result that runs the wrong way
If loose collagen made a loose bowel, a pressure catheter should show it. Researchers ran antroduodenal manometry (pressure tests of the stomach and upper gut) on 239 patients in a row with symptoms. Of these, 50 had hypermobility and 189 did not. Overall motion problems did not differ. Slow stomach emptying was about the same. And gut motion problems were actually less common in the hypermobile group, 13% against 34%, p = 0.006.
That result cuts against the tidy theory, and we should say so plainly. It came from one specialty unit. It had no healthy comparison group. It measured movement, not barrier or structure. Still, the symptom pattern agrees with it. The most common single gut complaint in the meta-analysis was heartburn at 34.7%. The most common gut-brain disorder was trouble swallowing (functional dysphagia) at 34.2%. Reflux ran 41.3%. That describes a swallow-and-valve problem with symptoms spread across the body, not a leaking hose. For a pain patient it matters because reflux and hard swallowing shape what you can eat, and eating is where tissue repair starts.
A wall rebuilt from what you eat
The gut lining is never finished. It rebuilds nonstop on a collagen-rich frame, out of material that has to come in by mouth. Eight healthy volunteers were fed only by vein for 14 days. Their total lining thickness dropped from 645 to 512 microns. Their lactulose-mannitol ratio, a sugar test of what slips between cells, rose from 0.06 to 0.11.
For anyone in pain, the detail that matters is the clock. After five days of food, thickness came back toward 575 microns. But the leak was still climbing, at 0.14. Structure and function do not heal on the same schedule. If you feel no better after a week of eating well, you are not failing treatment. The barrier just lags behind the structure. Blood glutamine did not fall during those two weeks of bowel rest either. So a normal blood level said nothing about a thinning lining.
Protein is the raw material, and chewing is a gut problem. When teeth or dentures hurt, protein is the first food to leave the plate. Pain that makes shopping, standing at a stove or sitting at a table hard pushes the same way. So does eating alone. That is why loneliness counts as a driver of unrelenting pain and not a side note. Count three normal days of protein before anyone orders another scan.
Collagen powder, glutamine and the safety line
Hydrolyzed collagen has a real place in the pain research, just not in the gut. A systematic review of 36 randomized trials on bone, muscle and joints found joints to be the bright spot. People had less pain, better mobility and better ankle function. Muscle results were mixed. They were mostly positive when collagen came paired with exercise. Bone studies were too few to conclude much, and one author had ties to a collagen ingredient business. The strongest case for the powder is a joint. The strongest condition is that you also train.
For the gut wall itself, no randomized collagen trial has a gut arm. The barrier claim on the label traces back to rats with chemically induced colitis. The exercise half of that equation is not optional in a hypermobile body. Read how losing muscle affects the body’s own anti-inflammatory signaling.
Glutamine is the amino acid the rat gut burns before glucose. In people, the results split. A randomized trial in post-infectious irritable bowel syndrome saw 79.6% respond to glutamine against 5.8% on placebo. But ten pooled adult trials of oral glutamine found no change in gut leakiness. Those two results answer different questions. The practice works from the mechanism for the patient in the room. But glutamine is not a harmless tonic. In 1,223 critically ill patients with multiorgan failure, it carried a 28-day death rate of 32.4% against 27.2%. The sicker the body, the less casual a supplement can be. That decision belongs with your physician.
What a pain practice does with a hypermobile body
Our position is to treat the tissue and the nervous system together. That means counting protein and fixing the mouth that has to chew it. It means reading the drug list for anything that could injure the lining. It means pairing any collagen use with loading, because that is where the joint evidence lives. It means taking reflux and swallowing seriously as part of the pain picture. And it means screening for the fatigue, migraine and dizziness on standing that come with this body type, not filing them under anxiety. Where we find a specific pain source, interventional care buys the window for that rebuilding to happen.
Two body drivers sit under all of it. One is a collagen frame built wrong. The other is a lining starved of the material to rebuild. And there is one social driver: a system that takes more than two decades to name the condition, while collagen research money flows toward skin. The earlier installment, Chapter 6, on the normal B12 that was not normal, covers the stomach machinery that pulls nutrients from food. Chapter 8, Your Gut Wall Is What You Fried Last Week, turns to the fats in every cell membrane of that lining. For every study here, open the Chapter 7 Deep Dive, where each one sits with its full numbers, its limits and the questions worth asking.
Frequently asked questions
Does Ehlers-Danlos syndrome cause stomach and bowel problems?
Very often. In pooled studies of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder, the odds of chronic gut symptoms were 4.29 times those of controls. Heartburn, reflux and trouble swallowing were among the most common complaints. That pattern points to the valves and the swallow more than to a slow bowel. Read why the leaky gut test you paid for cannot see the wall.
Why do people with hypermobility have so much pain and fatigue?
Collagen runs through joints, gut and blood vessels, so a collagen disorder shows up across the whole body. In a global survey, 98.9% of people with hypermobile Ehlers-Danlos reported chronic pain and 71.4% reported dysautonomia. Chronic fatigue affected 49% in pooled data. Treating one joint at a time misses the system. See how social isolation acts as an inflammatory state.
Does collagen supplementation help joint pain?
The best collagen evidence is for joints. A systematic review of randomized trials found less joint pain, better mobility and better ankle function. Muscle results were mostly positive only when collagen was combined with exercise. No collagen trial has tested the gut wall in people. So gut claims on the label are unproven for now. Learn where knee arthritis pain actually comes from.
Is glutamine safe to take for gut symptoms?
It depends on how sick you are. One trial in post-infectious irritable bowel syndrome found a large response. But pooled trials showed no change in gut leakiness. And in critically ill patients with multiorgan failure, glutamine was linked to higher 28-day death rates. It is not a casual supplement for a seriously ill body. Discuss it with your physician first. See which agents help rebuild a lining that is being fed.
Can a blood pressure medication affect the gut lining?
It can happen. In collagenous sprue, collagen builds up beneath the small-bowel lining. Of 38 patients with a recorded drug history, 30 had taken a drug linked to that injury, most often an angiotensin receptor blocker. That comes from pooled case reports, not a risk estimate. But a bowel change after a new prescription is worth raising with your physician. Explore other everyday exposures that drive pain.
Hypermobile and hurting everywhere?
In a hypermobile body, we look at the pain, the gut and the nervous system as one problem. Then we build a plan that feeds repair instead of chasing one joint at a time.
Request an appointment, or call or text us.
Sources
- Kulin, D., Holtmann, G., Fairlie, T., Staller, K., Nurko, S., Keefer, L., Drossman, D. A., Jones, M. P., Talley, N. J., & Ford, A. C. (2026). Meta-analysis: Chronic gastrointestinal symptoms and comorbidities in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Alimentary Pharmacology & Therapeutics, 64(5), 574–589. https://doi.org/10.1111/apt.70856
- Daylor, V., Griggs, M., Weintraub, A., Byrd, R., Petrucci, T., Huff, M., Byerly, K., Fenner, R., Gensemer, C., Norris, R. A., & Patel, S. (2025). Defining the chronic complexities of hEDS and HSD: A global survey of diagnostic challenges, life-long comorbidities, and unmet needs. Journal of Clinical Medicine, 14(16), 5636. https://doi.org/10.3390/jcm14165636
- Pepin, M., Schwarze, U., Superti-Furga, A., & Byers, P. H. (2000). Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. The New England Journal of Medicine, 342(10), 673–680. https://doi.org/10.1056/NEJM200003093421001
- Stirrat, T., Wilkey, M., Kim, S., Waterman, A., & Mattar, M. (2026). Collagenous sprue across five decades (1970-2025): A systematic review. Scandinavian Journal of Gastroenterology, 61(5), 577–585. https://doi.org/10.1080/00365521.2026.2641509
- Sweerts, K. W. E., Mujagic, Z., Keszthelyi, D., & Conchillo, J. M. (2025). Analysis of antroduodenal motility in patients with hypermobility spectrum disorders/hypermobile Ehlers-Danlos syndrome. Alimentary Pharmacology & Therapeutics, 61(4), 702-705. https://doi.org/10.1111/apt.18471
- Buchman, A. L., Moukarzel, A. A., Bhuta, S., Belle, M., Ament, M. E., Eckhert, C. D., Hollander, D., Gornbein, J., Kopple, J. D., & Vijayaroghavan, S. R. (1995). Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN. Journal of Parenteral and Enteral Nutrition, 19(6), 453–460. https://doi.org/10.1177/0148607195019006453
- Brueckheimer, P. J., Costa Silva, T., Rodrigues, L., Zague, V., & Isaia Filho, C. (2025). The effects of type I collagen hydrolysate supplementation on bones, muscles, and joints: A systematic review. Orthopedic Reviews, 17, 129086. https://doi.org/10.52965/001c.129086
- Zhou, Q., Verne, M. L., Fields, J. Z., Lefante, J. J., Basra, S., Salameh, H., & Verne, G. N. (2019). Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut, 68(6), 996–1002. https://doi.org/10.1136/gutjnl-2017-315136
- Abbasi, F., Haghighat Lari, M. M., Khosravi, G. R., Mansouri, E., Payandeh, N., & Milajerdi, A. (2024). A systematic review and meta-analysis of clinical trials on the effects of glutamine supplementation on gut permeability in adults. Amino Acids, 56(1), 60. https://doi.org/10.1007/s00726-024-03420-7
- Heyland, D., Muscedere, J., Wischmeyer, P. E., Cook, D., Jones, G., Albert, M., Elke, G., Berger, M. M., & Day, A. G. (2013). A randomized trial of glutamine and antioxidants in critically ill patients. The New England Journal of Medicine, 368(16), 1489–1497. https://doi.org/10.1056/NEJMoa1212722
Dr. Gurpreet Singh Padda, MD, MBA, MHP
